Soliris effective for PNH, even with bone marrow failure, study finds

Most Chinese adults and adolescents with paroxysmal nocturnal hemoglobinuria (PNH) no longer require blood transfusions after a median of six months of treatment with Soliris (eculizumab). That’s according to a small study at a single center in China, which also found the approved therapy to be safe and…

What blood donors mean to me as a transfusion recipient

Blood donors are silent heroes who aren’t recognized enough. As someone who’s received many blood transfusions, I couldn’t help but wonder how we got to this point of safely sharing healthy blood in hopes of saving lives. According to the American Red Cross, the history of blood transfusions began in…

Crovalimab effective, safe in PNH patients up to 4 years, study shows

Monthly injections of the experimental therapy crovalimab controlled red blood cell loss and the need for blood transfusions for up to four years in adults with paroxysmal nocturnal hemoglobinuria (PNH), according to data from a long-term extension study. In fact, more than 80% — and up to 92% —…